60 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
dismissal of the employment of the Executive by the Company.
Page 2 of 29
Bonus. The Executive is eligible to be considered for an annual discretionary … bonus which will be subject to the approval of the Board and the compensation committee of the Company, in their sole discretion, on an annual basis
8-K
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
and be eligible for an annual discretionary bonus, which will be subject to the approval of the Board and the compensation committee of the Company … bonus for Ms. Jagpal shall equal 40% of the base salary paid to Ms. Jagpal in the preceding 12-month period. Furthermore, pursuant to the terms
424B3
1dvrpf7qd gqiqio
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-99.1
rzrfn rz0on1mx
23 Sep 22
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
4:53pm
8-K
EX-10.1
tbum6
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
0ctgdf 3iip5m
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
zcpx4
15 Jul 22
Departure of Directors or Certain Officers
8:28pm
DEF 14A
by99oxcxi3gos
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
r3uxlhxz5v bzfzf0ry
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
6e73wl1
24 Sep 21
Annual report
7:31am
424B3
28z42ex7d6m5aw43m
22 Jul 21
Prospectus supplement
10:27am